Skip to main content
. 2022 Mar 9;45(7):1367–1377. doi: 10.1007/s40618-022-01771-0

Table 1.

Baseline characteristics stratified by sex

Variables Women
(n = 133)
Men
(n = 301)
p value
Age (years) mean ± SD 69.8 ± 11.5 65.4 ± 10.7  < 0.001
BMI (kg/m2) mean ± SD 26.3 ± 5.0 27.5 ± 4.0 0.009
Family Hx CVD 72 (55.8) 191 (64.7) 0.08
Smoking 25 (19.1) 86 (28.9) 0.031
Hypertension 97 (73.5) 246 (81.7) 0.05
Heart Failure 11 (8.3) 45 (14.9) 0.59
Dyslipidemia 61 (46.2) 162 (54.2) 0.12
Type 2 Diabetes 28 (21.2) 90 (29.9) 0.061
Known IHD 27 (20.4) 127 (42.2)  < 0.001
Prior AMI 18 (13.5) 92 (30.6)  < 0.001
Vascular Disease# 27 (20.4) 82 (27.2) 0.13
Prior Stroke/TIA 18 (13.6) 28 (9.3) 0.17
Dementia 1 (0.8) 2 (0.7) 0.91
End Stage Chronic Kidney/Dialysis 0 (0) 6 (1.9) 0.10
COPD 15 (11.4) 32 (10.6) 0.82
Statins at admission 50 (37.9) 148 (49.2) 0.029
Anti-platelets at admission  < 0.001
 Single 49 (37.1) 147 (48.8)
 DAPT 8 (6.1) 46 (15.3)
Acute Coronary Syndrome Yes 78 (58.6) 149 (49.5) 0.07
Type of CAD  < 0.001
 Obstructive CAD 83 (62.4) 236 (78.4)
 Non-obstructive CAD 50 (37.6) 65 (21.6)
Creatinine (mg/dl) mean ± SD 0.85 ± 0.30 1.07 ± 0.54  < 0.001
Platelet Count (× 103) mean ± SD 241.6 ± 71.5 209.8 ± 58.0  < 0.001
Hemoglobin (g/dL) media ± SD 13.1 ± 1.5 14.4 ± 1.6  < 0.001
Estradiol (pg/mL) median [IQR] 10.0 [9.5–17.0] 24.0 [16.0–31.0]  < 0.001
Testosterone (nmol/L) median [IQR] 0.8 [0.5–1.2] 14.1 [9.9–17.6]  < 0.001
T/E2 Ratio median [IQR] 1.8 [0.9–2.71] 15.8 [11.5–22.0]  < 0.001
Thromboxane (pg/ml), median [IQR]* 152.0 [116.0–187.0] 147.3 [96.0–220.6] 0.40
NO (uM) median [IQR]* 21.5 [12.5–30.2] 17.9 [8.1–38.8] 0.39

AMI Acute Myocardial Infarction, BMI body mass index, CAD coronary artery disease, COPD chronic obstructive pulmonary disease, DAPT dual-antiplatelet therapy, Hx history, PAD TIA transient ischemic attack

*Data available on 428 patients

#Peripheral artery disease and/or Carotid Stenosis